[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE128987T1 - Anregender wirkstoff für leydig-zellen. - Google Patents

Anregender wirkstoff für leydig-zellen.

Info

Publication number
ATE128987T1
ATE128987T1 AT92850089T AT92850089T ATE128987T1 AT E128987 T1 ATE128987 T1 AT E128987T1 AT 92850089 T AT92850089 T AT 92850089T AT 92850089 T AT92850089 T AT 92850089T AT E128987 T1 ATE128987 T1 AT E128987T1
Authority
AT
Austria
Prior art keywords
active ingredient
leydig cells
stimulating active
compound
stimulating
Prior art date
Application number
AT92850089T
Other languages
English (en)
Inventor
C Yan Cheng
C Wayne Bardin
Original Assignee
Population Council Center For
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Center For filed Critical Population Council Center For
Application granted granted Critical
Publication of ATE128987T1 publication Critical patent/ATE128987T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92850089T 1991-06-18 1992-04-16 Anregender wirkstoff für leydig-zellen. ATE128987T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/715,904 US5304603A (en) 1991-06-18 1991-06-18 Leydig cell stimulator

Publications (1)

Publication Number Publication Date
ATE128987T1 true ATE128987T1 (de) 1995-10-15

Family

ID=24875942

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92850089T ATE128987T1 (de) 1991-06-18 1992-04-16 Anregender wirkstoff für leydig-zellen.

Country Status (6)

Country Link
US (1) US5304603A (de)
EP (1) EP0519889B1 (de)
JP (1) JPH05271296A (de)
AT (1) ATE128987T1 (de)
CA (1) CA2065919A1 (de)
DE (1) DE69205342T2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2169128T3 (es) * 1994-04-13 2002-07-01 Res Corp Technologies Inc Procedimientos para el tratamiento de enfermedades utilizando celulas de sertoli y aloinjertos o xenoinjertos.
US5514119A (en) * 1994-08-19 1996-05-07 Curtis; John L. Embryo collection device
WO1996033264A1 (en) * 1995-04-20 1996-10-24 University Of South Florida Purified and isolated sertoli cell aggregate
US5851800A (en) * 1996-05-14 1998-12-22 Pharmacia & Upjohn Ab Process for producing a protein
DE19641378C1 (de) * 1996-09-27 1998-04-02 Ihf Inst Fuer Hormon Und Fortp Diagnosehilfe sowie Verfahren zum Nachweis der Trächtigkeit von Wiederkäuern
US20030055231A1 (en) * 1998-10-28 2003-03-20 Jian Ni 12 human secreted proteins
US7399751B2 (en) * 1999-11-04 2008-07-15 Sertoli Technologies, Inc. Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells
US7368527B2 (en) * 1999-03-12 2008-05-06 Human Genome Sciences, Inc. HADDE71 polypeptides
SE9902056D0 (sv) * 1999-06-03 1999-06-03 Active Biotech Ab An integrin heterodimer and an alpha subunit thereof
US6632938B2 (en) * 2001-06-07 2003-10-14 Isis Pharmaceuticals, Inc. Processes of purifying oligonucleotides
AU2004266126B8 (en) * 2003-07-03 2011-07-28 Sertoli Technologies, Llc Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3940067A1 (de) * 1989-12-04 1991-06-06 Max Planck Gesellschaft Steroidogenese induzierendes protein (sip)
US5166190A (en) * 1990-01-08 1992-11-24 Genentech, Inc. Method for increasing fertility in males

Also Published As

Publication number Publication date
DE69205342D1 (de) 1995-11-16
CA2065919A1 (en) 1992-12-19
US5304603A (en) 1994-04-19
EP0519889A3 (en) 1993-07-21
EP0519889A2 (de) 1992-12-23
EP0519889B1 (de) 1995-10-11
JPH05271296A (ja) 1993-10-19
DE69205342T2 (de) 1996-03-28

Similar Documents

Publication Publication Date Title
GT198400014A (es) Mejoras en o relativas a fenetanolaminas.
ATE128987T1 (de) Anregender wirkstoff für leydig-zellen.
ES432290A1 (es) Procedimiento para preparar composiciones fungicidas.
NO20006221L (no) Fremgangsmåte for bekjempelse av skadedyr
MX9304698A (es) Heterociclos que contienen nitrogeno substituido.
GR3030992T3 (en) Selective system scan for multizone radiotelephone subscriber units.
AU548290B2 (en) Para-substituted 3-phenoxy-1-alkylamino-propan-2-01 beta receptor blocking compounds
DE3176215D1 (en) Non-yellowing topical pharmaceutical composition
ES8700049A1 (es) Un procedimiento para la preparacion de una composicion topica para reducir la secrecion de sebo
IL65802A (en) 1-(3-fluoro-2-pyridinyl)piperazine and salts thereof,their preparation and pharmaceutical compositions containing them
GR3001375T3 (en) Enhancement of prazosin
ES8700054A1 (es) Procedimiento de obtencion de germicidas a base de acidos clorhidrico y fosforico.
ES400452A1 (es) Procedimiento para la obtencion de un medio para regular el crecimiento de las plantas a base de acidos 2-halogenoe- tano sulfinicos.
GB1025578A (en) 1,1-dicyclohexyl-2-(2-piperidyl)ethane
WO2000048446A3 (en) Use of antagonists of pg-e for the treatment of neuropathic pain
PT677051E (pt) Derivados de benzoil-ecgonina ecgonina e ecgonidina como medicamentos
ES8403487A1 (es) "procedimiento para la preparacion de n-(2-metoxietil)-noroximorfona".
ES8101538A1 (es) Procedimiento de preparacion de los aaa-trifluoro (aminoa- ril)etanoles o de un acido hetero arilcarboxilico,asi como de sus sales de adicion con un acido mineral u organico
SE9300106D0 (sv) Komposition foer att paaskynda saarlaekning
ATE73330T1 (de) Verwendung von pharmaceutischen zusammensetzungen fuer die herstellung von arzneimitteln fuer die behandlung psychiatrischer stoerungen.
ES451160A1 (es) Procedimiento para la obtencion de cromenos.
ES449874A1 (es) Procedimiento para la obtencion de un agente para el trata- miento de la mistitis bovina.
GB1097167A (en) 3-hydroxy-6-oxo-n-phenethylmorphinan compounds and their production
GT198302922A (es) 4-amino-6,7-dimetoxiquinolinas 2-substituidas.
ES402750A1 (es) Procedimiento para la preparacion de piensos para animales,con actividad estimulante del crecimiento.